Free Newsletters | Help  

  Current | By Company | NEW Products
Login ID:    Password:    Register for a FREE account
 NEWS

Industry News
Business
Organic
Food & Beverage
Sports Nutrition
Nutraceuticals
Regulatory
Research
Products
Practitioners
Retail
Events
People
On-line


 LISTINGS
  Categories
Products

Profiles
Publishers

 OPINION
  Editorials
Interviews
Up and Comers
Quality Initiatives

 
Blogs
Andrew Stewart  
Marc Ullman FYI Blog
Len Monheit Off The Cuff
James S. Tonkin - Formulating Beverages  
Jim Lassiter -- Good News/Bad News
The Nutrition Business Journal Blog

Join the NPIcenter LinkedIn Group Group
Join the Facebook page Page
Follow us on
Join the Facebook page


 FEATURES
 

Newsletter

  News Feeds
 
 SERVICES
  Log in
Register User
Add Company
Career Center
Advertise

 INFO CENTER
  Help
Contact Us
About NPI
Privacy Policy



 

Advertisement



Share Subscribe to NPIcenter Newsfeed

Findings Presented at the OsteoArthritis Research Society
2007-12-09 - Bergstrom Nutrition




International (OARSI) Conference, December 6, 2007

Abstract to be Published in Peer-Reviewed Osteoarthritis and Cartilage Journal

San Diego, CA, December 7, 2007—Researchers from the University of California, San Diego presented new research findings yesterday at the 2007 World Congress on Osteoarthritis in Ft. Lauderdale, providing the first evidence of how methylsulfonylmethane (MSM) may protect articular cartilage and reduce inflammation in osteoarthritis.  The form of MSM used in the study, OptiMSM was provided by Bergstrom Nutrition, Vancouver WA . 

The study examined the effect of OptiMSM on healthy and osteoarthritic articular cartilage from post mortem human knees.  Researchers focused on the expression of specific genes related to cartilage degradation and markers of inflammation, called cytokines. Over-expression of these genes and their related proteins are associated with the progression of osteoarthritis.

The study showed reduced expression of genes for pro-inflammatory cytokines and cartilage degrading enzymes.  “It suggests that MSM acts as a barrier, shielding cartilage in early stages of osteoarthritis from further degeneration from inflammatory cytokines and cartilage degrading enzymes,” says cartilage biology expert and lead researcher, David Amiel, Ph.D., Connective Tissue Biochemistry, Department of Orthopaedic Surgery, University of California San Diego.  The research team also included Yasushi Oshima, M.D., Ph.D. “This initial exploratory study aligns with the clinical evidence previously published by Kim et al. in Osteoarthritis and Cartilage Journal, March 2006, both on OptiMSM,” Dr. Amiel added. 

The researchers point out that, while the in vitro study is significant in revealing the protective action of OptiMSM, additional investigations are required to specify the optimum dose concentration for use in supplements by humans. The generally recommended dosage is 1,500 to 6,000 mg of MSM per day. More research is being planned for 2008.  Abstracts of research available at www.msmguide.com
 
About Bergstrom Nutrition

Bergstrom Nutrition based in Vancouver, Washington, introduced MSM to the human market in 1989. Its flagship product, OptiMSM, is the only MSM backed by U.S. published clinical research. OptiMSM is made entirely in the U.S., in the only NPA cGMP facility solely dedicated to MSM manufacturing.  OptiMSM is available in 18 countries and can be found in brands such as OsteoBiFlex, MoveFree, Nature’s Way, Jarrow Formulas, Nature’s Sunshine, Solaray, Natural Factors, and Vitamin Shoppe. For information visit www.bergstromnutrition.com.

#   #  #

 

Advertisement



Sponsored Links: Featured Links:
 

NPIcenter Address and Phone Number
Contact Us | Privacy Policy | Terms of Use | Advertise
New Hope Natural Media

 

SUPPLYEXPO Funtional Foods & Nutraceuticals Magazine Healthy Foods Conferences The Newport Summit - Executive Retreat Nutracon